Awarded Contractocds-r6ebe6-0000621914
Rituximab (MabThera) Subcutaneous Vial
The supply of rituximab (MabThera) subcutaneous vials to NHS Scotland.
Buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
Value
£13,728,768
Published
7 Jul 2020
Closes
7 Jul 2020
Procurement details
Source
Pcs
Region
Scotland
Procurement method
Limited
Category
Goods
Contract starts
Not provided
Contract ends
Not provided
CPV classifications
33600000
Pharmaceutical products
Lots
Lot 1 Rituximab (MabThera) Subcutaneous Vial
£13,728,768
The supply of rituximab subcutaneous vials to NHS Scotland.
Delivery: United Kingdom
Documents
Unlock document linkRituximab (MabThera) Subcutaneous Vial
Not provided
The supply of rituximab (MabThera) subcutaneous vials to NHS Scotland.
Award notice · Web page
Rituximab (MabThera) Subcutaneous Vial
Not provided
The supply of rituximab (MabThera) subcutaneous vials to NHS Scotland.
Award notice · Web page
Contains public sector information licensed under the Open Government Licence v3.0.